PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia
PembroWM:一项 II 期临床试验,旨在研究利妥昔单抗和帕博利珠单抗治疗复发/难治性华氏巨球蛋白血症的安全性和有效性。
期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.19706
Kothari, Jaimal; Eyre, Toby; Rismani, Ali; Ediriwickrema, Kushani; Edwards, Darren; Galani, Sevasti; Wilson, William; Lawrie, Anthony; Clifton-Hadley, Laura; McCarthy, Helen; Collins, Angela; Lewis, David; Arulogan, Suzanne; Auer, Rebecca; Pratt, Guy; de Tute, Ruth; Owen, Roger; D'Sa, Shirley